Archontogeorgis Kostas, Nena Evangelia, Papanas Nikolaos, Steiropoulos Paschalis
M.Sc. Program "Sleep Medicine", Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Breathe (Sheff). 2018 Sep;14(3):206-215. doi: 10.1183/20734735.000618.
Obstructive sleep apnoea syndrome (OSAS) is a common disorder of multifactorial pathogenesis and is associated with obesity, diabetes and cardiovascular disease. Vitamin D is a fat-soluble vitamin with an important function in calcium absorption and homeostasis, which is also implicated in several nonskeletal conditions. The prevalence of vitamin D deficiency is increasing worldwide and is associated with similar metabolic disturbances to OSAS. Moreover, recent data suggest that in OSAS patients serum levels of vitamin D are lower compared with non-apnoeic subjects. However, the mechanisms linking vitamin D deficiency and OSAS are not completely understood and several hypotheses have been advanced. To date, a limited number of studies have assessed the association between lower serum concentrations of vitamin D and OSAS, and have reported inconsistent results. Similarly, contradictory results have been produced by studies which evaluated the effect of continuous positive airway pressure treatment on serum vitamin D levels. The aim of this review is to summarise current knowledge on the association between OSAS and vitamin D levels.
Vitamin D insufficiency prevalence is increasing worldwide and presents with similar comorbidities and risk factors to OSAS.The nonskeletal actions of vitamin D may contribute to the development of OSAS through immune system modulation, myopathy and inflammation.Studies evaluating serum vitamin D concentrations in OSAS patients and the effect of CPAP treatment report contradictory results, often influenced by confounding factors, such as obesity.There appears to be potential for use of vitamin D supplementation in OSAS patients as a means of reducing the incidence of cardiovascular disease, a comorbidity common in both conditions.
To assess the potential association between OSAS and serum levels of vitamin D.To discuss the pathogenetic mechanisms linking OSAS and vitamin D insufficiency.To illustrate the effect of CPAP treatment on vitamin D concentration in OSAS patients.
阻塞性睡眠呼吸暂停综合征(OSAS)是一种多因素发病机制的常见疾病,与肥胖、糖尿病和心血管疾病相关。维生素D是一种脂溶性维生素,在钙吸收和体内平衡中具有重要作用,也与多种非骨骼疾病有关。全球维生素D缺乏的患病率正在上升,且与OSAS存在相似的代谢紊乱。此外,最近的数据表明,与非呼吸暂停受试者相比,OSAS患者的血清维生素D水平较低。然而,维生素D缺乏与OSAS之间的联系机制尚未完全明确,已经提出了几种假说。迄今为止,仅有少数研究评估了血清维生素D浓度降低与OSAS之间的关联,且结果并不一致。同样,评估持续气道正压通气治疗对血清维生素D水平影响的研究也得出了相互矛盾的结果。本综述的目的是总结当前关于OSAS与维生素D水平之间关联的知识。
全球维生素D不足的患病率正在上升,其合并症和风险因素与OSAS相似。维生素D的非骨骼作用可能通过免疫系统调节、肌病和炎症促进OSAS的发展。评估OSAS患者血清维生素D浓度以及CPAP治疗效果的研究报告结果相互矛盾,这些结果常受肥胖等混杂因素影响。在OSAS患者中补充维生素D似乎有可能作为降低心血管疾病发病率的一种手段,心血管疾病是这两种疾病共有的常见合并症。
评估OSAS与血清维生素D水平之间的潜在关联。讨论OSAS与维生素D不足之间的发病机制。阐述CPAP治疗对OSAS患者维生素D浓度的影响。